Garton & Associates Financial Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Garton & Associates Financial Advisors's AMGN Position: Q1 2026 in Review
Garton & Associates Financial Advisors sold out of Amgen (AMGN) in Q1 2026, closing a stake of 158 shares — an estimated $51.6K sold.
Garton & Associates Financial Advisors first reported a position in AMGN in Q4 2025 and held it in 1 quarter. The position peaked at $51.6K in Q4 2025. 3,142 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Garton & Associates Financial Advisors reported no remaining Amgen position as of Q1 2026 after selling out during the quarter.
- Garton & Associates Financial Advisors sold 158 Amgen shares in Q1 2026, an estimated $51.6K.
- Garton & Associates Financial Advisors first reported a position in Amgen in Q4 2025 and held it in 1 quarter.
- Garton & Associates Financial Advisors's Amgen position peaked at $51.6K in Q4 2025.
- 3,142 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Garton & Associates Financial Advisors's 13F filing for Q1 2026, filed 11 May 2026.